Page last updated: 2024-09-03

teloxantrone and Neoplasms

teloxantrone has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BĂ©langer, K; Eisenhauer, E; Grillo-Lopez, A; Jolivet, J; Maroun, J; Stewart, D; Wainman, N; Whitfield, L1
Eisenhauer, E; Erlichman, C; Kerr, IG; Moore, M; Whitfield, LR; Wong, B; Zee, B1

Trials

2 trial(s) available for teloxantrone and Neoplasms

ArticleYear
Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole.
    Investigational new drugs, 1993, Volume: 11, Issue:4

    Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Administration Schedule; Female; Hematologic Tests; Humans; Injections, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Pyrazoles

1993
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937).
    Cancer research, 1991, Dec-01, Volume: 51, Issue:23 Pt 1

    Topics: Adult; Aged; Agranulocytosis; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutropenia; Pyrazoles

1991